Search by keyword

30 result(s) found, displaying 1 to 20 | Clear filters

2020
Guide, user guide or guidelines

The Commission has revised the National Tall Man Lettering List to include cloBAZam in the benzodiazepine class of medicines, based on the reporting of adverse events and near misses and its high similarity and likelihood of confusion with another benzodiazepine: CLONAZepam.

2020
Publication, report or update

Version 1.2 updated in August 2020

2020
Guide, user guide or guidelines

This User Guide describes best practice strategies under each of the 28 specific actions to support organisations to deliver effective medication management in cancer services.

2020
Guide, user guide or guidelines

The purpose of this guide is to provide clinicians with evidence-based strategies to support them to understand and fulfil their roles and responsibilities. It combines information from a range of existing guides and resources, including the National Safety and Quality Health Service Standards User Guide for Medication Management in Cancer Care.

2020
Publication, report or update

This publication summarises medicines that were in use or being investigated to treat COVID-19 as at 7 October 2020. This publication remains available for reference but the information has not been updated since October 2020. The Commission acknowledges the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists for their contribution to this work.

For current resources, the National COVID-19 Clinical Evidence Taskforce has been established to provide evidence-based recommendations to guide care for people with COVID-19. The Taskforce undertakes detailed analyses of medicines for use in the treatment of COVID-19 which are updated as new research becomes available. The reviews are accompanied by therapy recommendations established through a consultation process.

Last updated 7 October 2020

2020
Publication, report or update

The Commission has developed Australia's response to the World Health Organization (WHO) Global Patient Safety Challenge: Medication without harm.

2020
Guide, user guide or guidelines

Last updated 27 August 2020

2020
Guide, user guide or guidelines

Last updated 28 April 2020

2020
Guide, user guide or guidelines

Last updated 29 April 2020

2020
Guide, user guide or guidelines

Last updated 15 May 2020

2020
Guide, user guide or guidelines

Last updated 28 April 2020

2020
Guide, user guide or guidelines

Last updated 28 April 2020

2020
Guide, user guide or guidelines

Last updated 29 April 2020

2020
Guide, user guide or guidelines

Last updated 28 April 2020

2020
Guide, user guide or guidelines

Last updated 12 May 2020

2020
Guide, user guide or guidelines

This guidance outlines strategies and principles developed to address safe selection and storage of all medicines, including look-alike, sound-alike (LASA) medicines.